PARK — Park Dental Partners, Inc. Common Stock

Summary of Park Dental Partners Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $61.2 million, up 7.5% year-over-year.
• Full-Year Revenue: $244.5 million, reflecting a 6.4% increase.
• Same Practice Revenue Growth: 5.8% for the full year; 6.3% in Q4.
• General Practice Revenue: Grew 4.8% to $179 million; Multi-specialty revenue rose 11% to $65.5 million.
• Adjusted EBITDA: Specific figures not disclosed, but noted to be strong.
• Patient Retention Rate: High at 89.9%.
• Operating Cash Flow: $17.6 million for the year; cash and cash equivalents stood at $25.2 million.
• Long-term Debt: $10.1 million, decreased by $1.9 million year-over-year.

2. Strategic Updates and Business Highlights

• Employee Engagement: Launched an employee stock purchase plan to enhance ownership among doctors and team members.
• Growth Strategy: Focused on increasing the number of doctors through practice acquisitions and opening new locations, with plans to enter 2-3 new markets in the coming years.
• Technology Investments: Implemented AI tools for diagnostics and upgraded workforce management systems to improve productivity.
• New Practices: Opened a multi-specialty de novo practice in Rochester, Minnesota, and completed three acquisitions (two in Minnesota and one in Phoenix, Arizona).

3. Forward Guidance and Outlook

• 2026 Revenue Projection: Expected to range from $254 million to $258 million.
• Same Practice Revenue Growth: Forecasted at 3.5% to 5%.
• Adjusted EBITDA Outlook: Anticipated to be between $21 million and $23 million, or 8.3% to 8.9% of revenue.
• M&A Activity: Plans to remain disciplined in acquisitions, focusing on cultural fit and long-term value creation.

4. Bad News, Challenges, or Points of Concern

• IPO Costs: Incurred $2.7 million in one-time IPO transaction costs and $8.8 million in non-cash share-based compensation, impacting EPS.
• Increased Public Company Costs: Anticipated ongoing public reporting costs of $400,000 to $500,000 per quarter.
• Sales Cycle Variability: Length of sales cycle for acquisitions can vary significantly, which may affect growth timelines.
• Share Count Increase: Post-IPO share count increased to 4.25 million, with potential to rise to 6.6 million by 2028, which could dilute earnings per share.

5. Notable Q&A Insights

• M&A Pipeline: The company has a robust pipeline with good momentum, particularly in Arizona, with ongoing efforts to expand.
• Efficiency Implementation: The time to achieve company margins post-acquisition can vary, with some practices reaching efficiency in 3 months while others may take up to 18 months.
• Technology as a Differentiator: The company views its technology stack as a competitive advantage in attracting new practices and improving operational efficiency, though there are no current plans to sell these technologies externally.

Overall, Park Dental Partners reported a strong financial performance for Q4 2025, with strategic growth initiatives and a focus on technology investments, while also facing challenges related to IPO costs and the variability of acquisition timelines.